NovoCodex - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $93,531.69 +1.01%
Ethereum $1,777.15 +0.16%
BNB $608.71 +0.64%
Optimism $0.80 +5.04%
Arbitrum $0.35 +3.18%
Solana $152.91 +2.75%
Polygon $0.22 +2.77%
Cosmos $4.55 +3.72%
Avalanche $22.37 +0.99%

Bitcoin $93,531.69 +1.01%
Ethereum $1,777.15 +0.16%
BNB $608.71 +0.64%
Optimism $0.80 +5.04%
Arbitrum $0.35 +3.18%
Solana $152.91 +2.75%
Polygon $0.22 +2.77%
Cosmos $4.55 +3.72%
Avalanche $22.37 +0.99%

NovoCodex

company

Summary
Funding Rounds
Investors

About

NovoCodex has been engaged in the business of genetic engineering, and cell culture, among others.

Highlights

Total Funding Amount

Details

Last Funding Type: Series A
Last Funding Money Raised: ¥400M
Industries: Clinical Trials,Health Care,Product Research
Founded date: Jan 1, 2015
Operating Status: Active

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

¥400M

NovoCodex has raised a total of ¥400M in funding over 2 rounds. Their latest funding was raised on Mar 19, 2021 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Mar 19, 2021	Series A	¥400M	1	Lilly Asia Ventures	—	Detail

Investors

Number of Lead Investors

Number of Investors

1

1

NovoCodex is funded by 1 investors. Lilly Asia Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Lilly Asia Ventures	Yes	Series A